Showing results (31-40 of 77) with videos related to

Sort By:
Pageof 8
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 22, 2005
Evaluating the expression and prognostic value of TRAIL-R1 and TRAIL-R2 in breast cancerMary M McCarthy, Mario Sznol, Kyle A DiVito, et al.
Journal of Clinical Pathology|October 16, 2014
PAX-8 expression in renal tumours and distant sites: a useful marker of primary and metastatic renal cell carcinoma?Meaghan L Barr, Lucia B Jilaveanu, Robert L Camp, et al.
Cancer Research|December 3, 2004
Automated quantitative analysis of tissue microarrays reveals an association between high Bcl-2 expression and improved outcome in melanomaKyle A Divito, Aaron J Berger, Robert L Camp, et al.
Breast Cancer Research : BCR|September 3, 2010
Benefits of biomarker selection and clinico-pathological covariate inclusion in breast cancer prognostic modelsFabio Parisi, Ana M Gonzalez, Yasmine Nadler, et al.
Breast Cancer Research : BCR|April 24, 2008
Expression patterns and prognostic value of Bag-1 and Bcl-2 in breast cancerYasmine Nadler, Robert L Camp, Jennifer M Giltnane, et al.
Cancer Research|April 6, 2007
High HSP90 expression is associated with decreased survival in breast cancerElah Pick, Yuval Kluger, Jennifer M Giltnane, et al.
BMC Clinical Pathology|February 5, 2013
Expression of drug targets in primary and matched metastatic renal cell carcinoma tumorsSaadia A Aziz, Joshua A Sznol, Adebowale Adeniran, et al.
International Journal of Cancer|December 21, 2002
Tissue microarray-based analysis shows phospho-beta-catenin expression in malignant melanoma is associated with poor outcomeEric Kielhorn, Elayne Provost, Drew Olsen, et al.
Melanoma Research|June 5, 2004
Her2/neu is not a commonly expressed therapeutic target in melanoma -- a large cohort tissue microarray studyHarriet M Kluger, Kyle DiVito, Aaron J Berger, et al.
Thrombosis and Haemostasis|March 12, 2009
Expression and prognostic significance of kallikrein-related peptidase 8 protein levels in advanced ovarian cancer by using automated quantitative analysisPanteleimon Kountourakis, Amanda Psyrri, Andreas Scorilas, et al.
Pageof 8